Recombinant Bacillus subtilis Proline dehydrogenase 1 (fadM)

What is the genetic organization of the proline utilization system in B. subtilis?

The proline utilization system in Bacillus subtilis is encoded by the putBCP operon (formerly known as ycgMNO). This gene cluster contains three key components:

• putB: Encodes proline dehydrogenase (PRODH)

• putC: Encodes Δ1-pyrroline-5-carboxylate dehydrogenase (P5CDH)

• putP: Encodes a high-affinity proline transporter

These genes are organized in a single operon that is transcribed as an L-proline-inducible unit under the control of a SigA-type promoter. The expression is mediated by the proline-responsive activator protein PutR, which responds to external L-proline at submillimolar concentrations .

How does proline catabolism function in B. subtilis?

Proline catabolism in B. subtilis follows a two-step enzymatic process:

• Proline dehydrogenase (PutB) oxidizes L-proline to Δ1-pyrroline-5-carboxylate (P5C), which spontaneously hydrolyzes to γ-glutamate-5-semialdehyde

• P5C dehydrogenase (PutC) further oxidizes this intermediate to L-glutamate using NAD as a cofactor

This pathway positions L-glutamate as a central metabolite at the intersection of carbon and nitrogen metabolism in B. subtilis. The process is similar to that found in other bacteria but with specific regulatory features unique to B. subtilis .

How is the putBCP operon regulated in B. subtilis?

The putBCP operon in B. subtilis is regulated through multiple mechanisms:

• External L-proline induces expression via the PutR activator protein at concentrations in the submillimolar range

• CodY, a negative regulatory protein, can displace PutR from the putBCP promoter region, establishing repression when specific nutritional conditions are met

• Remarkably, B. subtilis can distinguish between external L-proline and internal L-proline pools generated through de novo synthesis

• High intracellular concentrations of L-proline synthesized as a stress protectant (up to several hundred millimolar) do not trigger putBCP expression

This sophisticated regulation prevents a futile cycle of L-proline synthesis and degradation when B. subtilis faces high-osmolarity environments .

What expression systems are most effective for recombinant production of B. subtilis proline dehydrogenase?

For recombinant expression of B. subtilis proline dehydrogenase (PutB), several systems can be considered:

• Homologous expression in B. subtilis:

  • Advantages: Native cellular environment, proper folding, potential for secretion

  • Approach: Integrate the putB gene into the chromosome at the amyE locus using a double-recombination event

  • Recommended vectors: pDG1662 derivatives with strong promoters (e.g., P43 or PgsiB)

  • Selection markers: Chloramphenicol resistance (5 μg/ml) is commonly used

• Heterologous expression in E. coli:

  • Advantages: High yield, ease of purification with affinity tags

  • Recommended vectors: pET system with His-tag for easy purification

  • Induction conditions: 0.1-1.0 mM IPTG at OD600 0.6-0.8

• Expression with phosphopantetheinyl transferase (Sfp):

  • If post-translational modifications are required, co-expression with Sfp can be beneficial

  • Sfp has shown versatility in modifying heterologous recombinant proteins

What are optimal growth conditions for maximal expression of recombinant PutB in B. subtilis?

Optimal growth conditions for recombinant PutB expression in B. subtilis include:

• Medium composition:

  • Spizizen's minimal medium (SMM) supplemented with 15 mM NH4Cl as nitrogen source

  • When using glucose as carbon source: 28 mM concentration

  • When using L-proline as carbon source: 32 mM (provides equivalent carbon atoms)

  • Trace elements and appropriate antibiotics for selection

• Induction parameters:

  • L-proline concentration: 1-2 mM for optimal induction of the putBCP promoter

  • Growth phase: Mid-logarithmic phase (OD600 ≈ 0.4-0.6)

  • Temperature: 37°C for growth, potential reduction to 30°C post-induction

• Antibiotic concentrations for selection:

  • Chloramphenicol: 5 μg/ml

  • Kanamycin: 10 μg/ml

  • Tetracycline: 15 μg/ml

  • Erythromycin: 1 μg/ml

  • Spectinomycin: 100 μg/ml

How can I design reporter systems to study putBCP regulation in B. subtilis?

Effective reporter systems for studying putBCP regulation include:

• Transcriptional fusions using treA:

  • The putB-treA fusion approach allows quantitative measurement of promoter activity

  • Construction method: Clone the putB promoter region upstream of the treA gene (encoding phospho-α-(1,1)-glucosidase)

  • Integration: Stably integrate at the amyE locus via double-recombination

  • Measurement: Quantify enzyme activity using a colorimetric assay

• Northern blotting for transcript analysis:

  • Preparation of RNA probes: Use in vitro transcription with DIG-labeled nucleotides

  • Probe templates: Utilize plasmids containing putB (e.g., pSM11), putC (e.g., pSM34), or putP (e.g., pSM35)

  • RNA isolation: Acidic phenol method yields high-quality RNA

  • Detection: RNA-RNA hybridization followed by immunological detection

• Primer extension for transcription start site identification:

  • Oligonucleotide design: Create primers complementary to the 5' region of putB

  • Labeling: Use infrared dyes (e.g., IRD-800) for sensitive detection

  • Analysis: Run on sequencing gels alongside a sequencing ladder for precise mapping

What methods are most effective for purifying recombinant PutB while maintaining enzymatic activity?

Purification of recombinant PutB with preserved activity requires:

• Buffer optimization:

  • Lysis buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 1 mM DTT

  • Addition of protease inhibitors: PMSF (1 mM) or commercial cocktails

  • FAD supplementation: 10-50 μM FAD in all buffers to maintain the flavin cofactor

• Purification strategy:

  • Affinity chromatography: N-terminal His6-tag followed by IMAC

  • Ion exchange: Q-Sepharose at pH 8.0 (PutB theoretical pI ≈ 5.5)

  • Size exclusion: Final polishing and buffer exchange step

  • Keep all steps at 4°C to minimize enzyme denaturation

• Activity preservation measures:

  • Avoid freeze-thaw cycles; store at -80°C in single-use aliquots

  • Include 10-20% glycerol in storage buffer

  • Maintain reducing environment with 1-5 mM DTT or β-mercaptoethanol

What assays can be used to measure proline dehydrogenase activity in recombinant B. subtilis strains?

Several assays can effectively measure proline dehydrogenase activity:

• Spectrophotometric assays:

  • DCPIP reduction: Monitor decrease in absorbance at 600 nm as 2,6-dichlorophenolindophenol is reduced

  • Artificial electron acceptors: Use INT (iodonitrotetrazolium) or MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) coupled with PMS (phenazine methosulfate)

  • NAD+/NADH coupling: If using coupled reaction with P5C dehydrogenase, monitor NADH formation at 340 nm

• Endpoint assays:

  • P5C formation: Measure using o-aminobenzaldehyde reaction (yellow chromophore, λmax = 443 nm)

  • Glutamate formation: Quantify using glutamate dehydrogenase coupling or HPLC analysis

• Kinetic parameters determination:

  • Varying L-proline concentrations (0.1-50 mM) to determine Km and Vmax

  • Measuring activity at different pH values (pH 6.0-9.0) for pH optima

  • Temperature range testing (25-60°C) for temperature optima and stability

How does PutB interact with other components of the proline utilization pathway?

PutB functions in a coordinated pathway with other components:

• Interaction with PutC:

  • PutB and PutC likely form a functional complex for efficient transfer of the P5C intermediate

  • The unstable P5C/γ-glutamate-5-semialdehyde intermediate can spontaneously cyclize or hydrolyze

  • Substrate channeling between PutB and PutC may prevent loss of intermediates

• Pathway integration:

  • PutB activity is coordinated with PutP-mediated proline uptake

  • Glutamate produced by the pathway feeds into central nitrogen metabolism

  • Under some conditions, the pathway may be coupled to electron transport chains

• Experimental approaches to study interactions:

  • Co-immunoprecipitation using tagged versions of PutB and PutC

  • Bacterial two-hybrid assays for protein-protein interaction detection

  • Fluorescence resonance energy transfer (FRET) using fluorescently labeled proteins

  • Size exclusion chromatography to analyze complex formation

How does B. subtilis proline dehydrogenase differ from similar enzymes in other bacterial species?

B. subtilis proline dehydrogenase exhibits several distinguishing features compared to other bacterial counterparts:

• Structural and functional differences:

  • B. subtilis uses separate monofunctional enzymes (PutB and PutC) for proline catabolism, unlike some bacteria that employ bifunctional PRODH-P5CDH enzymes

  • B. subtilis PutB is a flavin-containing enzyme with different cofactor binding properties than some homologs

  • The quaternary structure and oligomerization state may differ from other bacterial PRODHs

• Regulatory distinctions:

  • The regulation by PutR is specific to B. subtilis and closely related Bacilli

  • Unlike some bacterial systems, B. subtilis can discriminate between external and internal proline pools

  • The CodY-mediated repression of putBCP represents a unique regulatory circuit

• Comparative table of proline dehydrogenases across species:

What are the challenges in engineering B. subtilis for optimal proline dehydrogenase expression and activity?

Engineering B. subtilis for optimal PutB expression faces several challenges:

• Expression optimization challenges:

  • Balancing expression levels to avoid inclusion body formation

  • Maintaining appropriate redox environment for FAD cofactor incorporation

  • Optimizing codon usage for high-level expression

  • Managing potential toxicity of overexpression

• Pathway engineering considerations:

  • Preventing metabolic burden from overexpression

  • Balancing flux between proline catabolism and anabolism

  • Coordinating expression with other putBCP operon components

  • Modifying regulatory elements to achieve constitutive expression if desired

• Advanced engineering approaches:

  • CRISPR-Cas9 genome editing for precise chromosomal modifications

  • Promoter engineering using synthetic biology principles

  • Directed evolution to enhance specific properties of PutB

  • Protein engineering to modify substrate specificity or stability

How can recombinant B. subtilis PutB be utilized in biotechnological applications?

Recombinant B. subtilis PutB offers several potential biotechnological applications:

• Biocatalysis applications:

  • Conversion of proline to useful derivatives or intermediates

  • Integration into multi-enzyme cascades for complex transformations

  • Potential for whole-cell biocatalysis using engineered B. subtilis

• Biosensor development:

  • Creation of proline biosensors using PutB activity coupled to reporter systems

  • Environmental monitoring of proline levels in various samples

  • High-throughput screening platforms for directed evolution

• Metabolic engineering applications:

  • Incorporation into pathways for production of glutamate-derived compounds

  • Development of proline-based biorefinery concepts

  • Engineering of stress-resistant production strains utilizing proline metabolism

What are the key unresolved questions about B. subtilis proline dehydrogenase that warrant further research?

Several fundamental questions about B. subtilis PutB remain to be addressed:

• Molecular basis of external vs. internal proline discrimination:

  • How does B. subtilis distinguish between externally supplied and internally synthesized proline?

  • What molecular mechanisms prevent activation of putBCP expression by osmotically accumulated proline?

  • Are there specific cellular compartmentalization mechanisms involved?

• Structural and mechanistic aspects:

  • What is the three-dimensional structure of B. subtilis PutB?

  • How does electron transfer occur during catalysis?

  • What is the basis for substrate specificity and potential for accepting proline analogs?

• Systems-level integration:

  • How is proline catabolism coordinated with other metabolic pathways?

  • What is the role of proline metabolism in B. subtilis biofilm formation?

  • How does the proline utilization system interact with stress response networks?

What approaches can be used to study the in vivo dynamics of proline metabolism in B. subtilis?

Advanced approaches for studying in vivo proline metabolism include:

• Metabolic flux analysis:

  • 13C-labeled proline feeding experiments

  • Quantification of labeled metabolites using LC-MS/MS

  • Computational modeling to determine flux distributions

  • Integration with transcriptomic and proteomic data

• Real-time monitoring systems:

  • Fluorescent reporter fusions to monitor putBCP expression dynamics

  • Microfluidic systems for single-cell analysis of metabolic heterogeneity

  • Biosensor-based approaches for intracellular proline concentration measurement

  • Time-resolved sampling for metabolomics analysis

• In vivo protein interaction studies:

  • FRET or BRET analysis of PutB-PutC interactions

  • Split fluorescent protein complementation assays

  • Crosslinking approaches followed by mass spectrometry

  • ChIP-seq for analysis of PutR binding dynamics across different conditions

How can bioinformatic approaches contribute to understanding B. subtilis proline dehydrogenase evolution and function?

Bioinformatic approaches offer valuable insights into PutB evolution and function:

• Evolutionary analysis:

  • Phylogenetic analysis of PutB across Bacillus species and other bacteria

  • Identification of conserved catalytic residues and structural features

  • Analysis of selective pressures on proline metabolism genes

  • Horizontal gene transfer assessment of the putBCP operon

• Structural bioinformatics:

  • Homology modeling of PutB based on related enzymes

  • Molecular docking of substrates and potential inhibitors

  • Molecular dynamics simulations to understand conformational changes

  • Prediction of protein-protein interaction surfaces with PutC

• Systems biology integration:

  • Genome-scale metabolic modeling of proline metabolism

  • Gene co-expression network analysis across multiple conditions

  • Integration of transcriptomic, proteomic, and metabolomic datasets

  • Machine learning approaches to predict regulatory interactions affecting putBCP expression

What are common challenges when working with recombinant B. subtilis PutB and how can they be addressed?

Common challenges and their solutions include:

• Low expression yields:

  • Optimize codon usage for B. subtilis or E. coli depending on expression host

  • Test different promoters (P43, Pspac, PxylA) for optimal expression

  • Evaluate different growth media formulations and induction conditions

  • Consider fusion tags that enhance solubility (e.g., MBP, SUMO)

• Enzyme instability:

  • Include glycerol (10-20%) and reducing agents in all buffers

  • Supplement with FAD during purification and storage

  • Optimize pH and ionic strength of buffers

  • Explore additives that enhance protein stability (e.g., trehalose, arginine)

• Inconsistent activity measurements:

  • Standardize enzyme preparation methods

  • Control oxygen exposure during activity assays

  • Ensure consistent cofactor concentrations

  • Develop robust standard curves for quantification

• Inclusion body formation:

  • Lower expression temperature (25-30°C)

  • Reduce inducer concentration

  • Co-express molecular chaperones (GroEL/ES, DnaK system)

  • Optimize cell lysis conditions to maximize recovery of soluble protein

How can I optimize the putBCP promoter for controlled expression of recombinant proteins in B. subtilis?

Optimization of the putBCP promoter involves several strategies:

• Promoter engineering approaches:

  • Site-directed mutagenesis of core promoter elements

  • Modification of the PutR binding site to alter induction characteristics

  • Creation of hybrid promoters combining putBCP elements with constitutive promoters

  • Development of synthetic promoter libraries with varying strengths

• Regulatory circuit modifications:

  • Deletion of codY to remove negative regulation

  • Overexpression of putR to enhance promoter activation

  • Engineering of proline-independent variants of PutR

  • Implementation of orthogonal regulatory systems

• Experimental validation:

  • Use reporter genes (gfp, lacZ, treA) to quantify promoter strength

  • Determine dose-response curves with varying proline concentrations

  • Measure promoter activity across different growth phases

  • Test performance in different genetic backgrounds and media conditions

How should results from putBCP expression studies be interpreted in the context of B. subtilis metabolism?

Interpretation of putBCP expression data requires consideration of several factors:

• Physiological context:

  • Growth phase influences: expression patterns differ between exponential and stationary phases

  • Nutrient availability: carbon and nitrogen sources affect baseline expression

  • Environmental conditions: osmotic stress alters proline metabolism networks

  • Cell density effects: potential quorum-sensing influences on expression

• Integrated data analysis:

  • Correlate putBCP expression with cellular proline levels

  • Consider the relationship between proline transport (PutP) and catabolism (PutB, PutC)

  • Evaluate expression in relation to other metabolic pathways (TCA cycle, nitrogen metabolism)

  • Account for potential post-transcriptional regulation mechanisms

• Normalization and controls:

  • Use appropriate reference genes for qRT-PCR normalization

  • Implement controls for osmotic stress response genes

  • Compare with other amino acid catabolic pathways

  • Consider the influence of background strain mutations (e.g., trpC2, pheA1 in JH642)

What criteria should be used to validate engineered B. subtilis strains expressing recombinant PutB?

Comprehensive validation of engineered strains requires multiple levels of analysis:

• Genetic verification:

  • PCR confirmation of genetic modifications

  • Whole-genome sequencing to detect potential off-target mutations

  • Stability testing over multiple generations

  • Verification of plasmid maintenance or chromosomal integration

• Expression validation:

  • Western blotting for protein expression levels

  • Quantitative RT-PCR for transcript levels

  • Mass spectrometry for protein identification and modification analysis

  • Activity assays to confirm functional enzyme production

• Physiological characterization:

  • Growth curves under various conditions

  • Metabolic profiling to assess pathway integration

  • Stress response testing, particularly osmotic challenge

  • Competition assays with parental strains to assess fitness effects

• Performance metrics:

  • Enzymatic activity per cell or biomass unit

  • Substrate utilization rates

  • Product formation kinetics

  • Long-term stability under relevant conditions

What emerging technologies could advance our understanding of B. subtilis proline dehydrogenase?

Cutting-edge technologies for advancing PutB research include:

• Advanced structural biology approaches:

  • Cryo-electron microscopy for high-resolution structure determination

  • Time-resolved X-ray crystallography to capture catalytic intermediates

  • Hydrogen-deuterium exchange mass spectrometry for conformational dynamics

  • Integrative structural biology combining multiple experimental techniques

• Single-cell technologies:

  • Single-cell RNA-seq to study putBCP expression heterogeneity

  • Single-cell metabolomics to analyze proline metabolism at individual cell level

  • Microfluidics-based approaches for real-time monitoring of cellular responses

  • Super-resolution microscopy for subcellular localization studies

• Genome editing and synthetic biology:

  • CRISPR-Cas systems for precise genome manipulation

  • Minimal genome approaches to study essential functions

  • Cell-free expression systems for rapid prototyping

  • Computational design of novel proline metabolic pathways

How might fundamental research on B. subtilis proline dehydrogenase contribute to broader scientific knowledge?

Fundamental research on B. subtilis PutB has broader implications:

• Basic science contributions:

  • Deeper understanding of bacterial metabolic regulation

  • Insights into protein-protein interactions in metabolic pathways

  • Evolutionary perspectives on amino acid metabolism

  • Mechanisms of cellular adaptation to environmental fluctuations

• Methodological advances:

  • Development of novel enzyme assays and biosensors

  • Refinement of protein engineering approaches

  • Improvement of heterologous expression systems

  • Enhanced computational models of bacterial metabolism

• Cross-disciplinary applications:

  • Insights into human proline metabolism disorders

  • Agricultural applications for improving plant stress tolerance

  • Environmental science applications for bioremediation

  • Synthetic biology principles for constructing artificial metabolic pathways